Humedica Inc., which emerged from stealth mode in September with $30 million in financing from four local investment firms, named its scientific advisory board.
The Boston-based health informatics company named Paul Bleicher, John Halamka, Ashish Jha, Kenneth Kaitin, Isaac Kohane and David Nash to the board. Bleicher, the founding CEO of Waltham, Mass.-based Phase Forward is currently serving as Humedica’s chief medical officer.
The company, which was spun out of investment bank Leerink Swann, has been quietly amassing data since the summer of 2008, according to a WBZ radio interview with CEO Michael Weintraub.
Weintraub said the company was pulling together the “largest national consensus view of healthcare” by stockpiling clinical, financial and operational information from electronic health care records.
Humedica’s backers include Bain Capital Ventures, General Catalyst Partners, North Bridge Venture Partners and Leerink Swann.